Seelos Therapeutics Inc
General ticker "SEEL" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $10.5M
Seelos Therapeutics Inc does not follow the US Stock Market performance with the rate: -20.3%.
Estimated limits based on current volatility of 22.1%: low 0.80$, high 1.26$
Factors to consider:
- Current price 85.3% below predicted low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term predictions were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 predicted range: [6.95$, 41.82$]
- 2024-12-30 to 2025-12-30 predicted range: [4.41$, 19.49$]
Financial Metrics affecting the SEEL estimates:
- Negative: Non-GAAP EPS of -13.00 <= 0.08
- Negative: Operating Income to Revenue ratio of -0.95 <= 0.01
- Negative: Operating Cash Flow per share of -4.88 <= 0.20
- Negative: negative Net Income
Short-term SEEL quotes
Long-term SEEL plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $2.20MM |
| Operating Expenses | $61.67MM | $70.92MM | $42.70MM |
| Operating Income | $-61.67MM | $-70.92MM | $-40.50MM |
| Non-Operating Income | $-4.38MM | $-2.62MM | $2.62MM |
| Interest Expense | $1.60MM | $0.01MM | $0.07MM |
| R&D Expense | $46.65MM | $58.62MM | $30.12MM |
| Income(Loss) | $-66.05MM | $-73.53MM | $-37.88MM |
| Taxes | $1.49MM | $0.00MM | $0.00MM |
| Profit(Loss) | $-67.53MM | $-73.53MM | $-37.88MM |
| Stockholders Equity | $57.32MM | $-10.61MM | $-33.51MM |
| Assets | $83.50MM | $22.75MM | $5.42MM |
| Operating Cash Flow | $-48.99MM | $-61.60MM | $-23.91MM |
| Financing Cash Flow | $112.07MM | $-1.60MM | $11.38MM |
| Earnings Per Share* | $-22.29 | $-21.48 | $-7.73 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.